Get the Stockscreener App
7.45
5.46%
-0.43
Pre-market:
7.84
0.39
+5.23%
Inogen Inc stock is traded at $7.45, with a volume of 228.86K.
It is down -5.46% in the last 24 hours and down -30.11% over the past month.
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. Internationally, It sells its products through distributors large gas companies, and home oxygen providers. It generates the majority of its revenue in the United States.
See More
Previous Close:
$7.88
Open:
$7.83
24h Volume:
228.86K
Relative Volume:
0.84
Market Cap:
$176.71M
Revenue:
$331.52M
Net Income/Loss:
$-52.69M
P/E Ratio:
-3.3111
EPS:
-2.25
Net Cash Flow:
$-14.47M
1W Performance:
-4.61%
1M Performance:
-30.11%
6M Performance:
-34.25%
1Y Performance:
+4.34%
1-Day Range:
$7.40
$7.845
1-Week Range:
$7.315
$8.21
52-Week Range:
$6.14
$13.33
Inogen Inc Stock (INGN) Company Profile
Name
Inogen Inc
Sector
Industry
Phone
805-562-0500
Address
859 WARD DRIVE, GOLETA, CA
Compare INGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INGN
Inogen Inc
|
7.45 | 176.71M | 331.52M | -52.69M | -14.47M | -2.25 |
|
ABT
Abbott Laboratories
|
129.89 | 225.27B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.37 | 140.74B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.66 | 138.77B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
92.33 | 118.39B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
67.95 | 39.95B | 5.72B | 4.17B | 259.90M | 6.97 |
Inogen Inc Stock (INGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-15-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Aug-08-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-14-23 | Downgrade | Needham | Buy → Hold |
| Jan-17-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-09-21 | Upgrade | Needham | Hold → Buy |
| Nov-02-21 | Upgrade | JP Morgan | Underweight → Neutral |
| Aug-05-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-04-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Dec-14-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-20 | Downgrade | Needham | Buy → Hold |
| May-06-20 | Reiterated | Needham | Buy |
| Nov-06-19 | Upgrade | Needham | Hold → Buy |
| Sep-13-19 | Reiterated | Piper Jaffray | Overweight |
| Aug-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Aug-08-19 | Downgrade | Stifel | Buy → Hold |
| Aug-07-19 | Downgrade | Needham | Buy → Hold |
| Jun-28-19 | Downgrade | Needham | Strong Buy → Buy |
| May-08-19 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-19 | Reiterated | Needham | Strong Buy |
| Feb-27-19 | Reiterated | Needham | Strong Buy |
| Nov-20-18 | Upgrade | Needham | Buy → Strong Buy |
| Nov-07-18 | Reiterated | Needham | Buy |
| Sep-10-18 | Downgrade | Needham | Strong Buy → Buy |
| Aug-22-18 | Resumed | Stifel | Buy |
| Aug-08-18 | Reiterated | Needham | Strong Buy |
| Jun-06-18 | Initiated | KeyBanc Capital Mkts | Sector Weight |
| May-01-18 | Reiterated | Needham | Strong Buy |
| Feb-28-18 | Reiterated | Needham | Strong Buy |
View All
Inogen Inc Stock (INGN) Latest News
Inogen (INGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Here's Why You Should Retain Inogen Stock in Your Portfolio Now - Nasdaq
Why Investors Shouldn't Be Surprised By Inogen, Inc.'s (NASDAQ:INGN) 35% Share Price Plunge - Simply Wall St
Truist Financial Corp Has $104,000 Stake in Inogen, Inc. (NASDAQ:INGN) - Defense World
Inogen CFO Michael Bourque buys $24,960 in company stock - Investing.com India
Inogen CEO Kevin Merrill buys $100k in stock By Investing.com - Investing.com Australia
Insider Buying: Smith Kevin Raymond Merrill Acquires Shares of I - GuruFocus.com
Insider Buying: Michael Bourque Acquires Shares of Inogen Inc (I - GuruFocus.com
Inogen Executives Make Bold Moves with Major Stock Purchases! - TipRanks
Inogen CEO Kevin Merrill buys $100k in stock - Investing.com India
Medical Oxygen Systems Market Is Booming Worldwide 2025-2032: Koninklijke Philips N.V, Inogen, Inc., BOC - EIN News
A Volatile Share Price Masks Some Of The Progress At Inogen (NASDAQ:INGN) - Seeking Alpha
Inogen (NASDAQ:INGN) Releases Quarterly Earnings Results - MarketBeat
Inogen’s (INGN) “Hold” Rating Reiterated at Needham & Company LLC - Defense World
Inogen's (INGN) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Inogen Inc SEC 10-K Report - TradingView
Inogen, Inc. (NASDAQ:INGN) Released Earnings Last Week And Analysts Lifted Their Price Target To US$10.00 - Simply Wall St
Inogen (NASDAQ:INGN) Rating Lowered to Hold at StockNews.com - Defense World
StockNews.com Downgrades Inogen (NASDAQ:INGN) to Hold - MarketBeat
Inogen Inc’s Earnings Call: Growth Amid Challenges - TipRanks
Inogen Adds Mira Kirti Sahney to its Board - MPO-mag
What's Going On With MedTech Focused Inogen Stock On Wednesday? - Benzinga
Inogen, Inc. (NASDAQ:INGN) Q4 2024 Earnings Call Transcript - Insider Monkey
Inogen (NASDAQ:INGN shareholders incur further losses as stock declines 10% this week, taking five-year losses to 78% - Simply Wall St
Inogen: Q4 Earnings Snapshot - CTPost
Inogen, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Inogen Inc (INGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... By GuruFocus - Investing.com Canada
Inogen Inc (INGN) Q4 2024 Earnings Call Highlights: Revenue Grow - GuruFocus.com
Inogen Inc (INGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic Partnerships ... - Yahoo Finance
Inogen Inc earnings beat by $0.20, revenue topped estimates - Investing.com
Inogen Reports Strong Revenue Growth in 2024 - TipRanks
Earnings call transcript: Inogen Q4 2024 beats earnings expectations - Investing.com India
INGN Stock Gains Following Q4 Earnings Beat, Adjusted Gross Margin Up - MSN
Earnings call transcript: Inogen Q4 2024 beats earnings expectations By Investing.com - Investing.com Canada
Inogen Announces Fourth Quarter and Full Year 2024 Financial Results - sharewise
Inogen Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Inogen (INGN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
The Zacks Analyst Blog Highlights Fresenius Medical, Masimo, Merit Medical Systems and Inogen - Yahoo Finance
Inogen Inc (INGN) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Inogen (INGN) Projected to Post Quarterly Earnings on Tuesday - Defense World
Inogen Inc expected to post a loss of 61 cents a shareEarnings Preview - TradingView
Inogen, Inc. (NASDAQ:INGN) Short Interest Up 8.8% in January - MarketBeat
Inogen, Inc. to Host Earnings Call - ACCESS Newswire
Charlotte Buffoni Appointed to Inogen Alliance Leadership Team - 3BL Media
Inogen (NASDAQ:INGN) Shares Pass Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Short Interest in Inogen, Inc. (NASDAQ:INGN) Increases By 8.8% - Defense World
Inogen (NASDAQ:INGN) Stock Rating Upgraded by StockNews.com - MarketBeat
Inogen Inc Stock (INGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Inogen Inc Stock (INGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bourque Michael J. | EVP, CFO & Treasurer |
Mar 03 '25 |
Buy |
8.32 |
3,000 |
24,960 |
47,646 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 01 '25 |
Option Exercise |
0.00 |
28,333 |
0 |
44,387 |
| Smith Kevin Raymond Merrill | CEO and President |
Mar 03 '25 |
Buy |
8.56 |
11,709 |
100,245 |
70,274 |
| Smith Kevin Raymond Merrill | CEO and President |
Dec 01 '24 |
Option Exercise |
0.00 |
28,333 |
0 |
28,333 |
| Ramade Gregoire | Chief Commercial Officer |
Dec 01 '24 |
Option Exercise |
0.00 |
31,565 |
0 |
31,565 |
3.40%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):